Paul A. Jones - Feb 7, 2022 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Role
Chief Leadership Dev Officer
Signature
Josh Foukas, as attorney in fact.
Stock symbol
USNA
Transactions as of
Feb 7, 2022
Transactions value $
-$44,510
Form type
4
Date filed
2/10/2022, 02:02 PM
Previous filing
Feb 8, 2022
Next filing
Aug 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction USNA Common Stock Options Exercise +1.46K +18.86% 9.18K Feb 8, 2022 Direct F1
transaction USNA Common Stock Tax liability -$44.5K -472 -5.14% $94.30 8.71K Feb 8, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USNA Restricted Stock units Award $0 +5.49K +62.78% $0.00 14.2K Feb 7, 2022 Common Stock 5.49K Direct F1, F3
transaction USNA Restricted Stock Units Options Exercise $0 -1.46K -10.24% $0.00 12.8K Feb 8, 2022 Common Stock 1.46K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
F2 Restricted Stock Units vest 25% on the anniversary of February 8th, 2021.
F3 On February 7th, 2022, the reporting person was granted restricted stock units, vesting at 25% on each 7th of February thereafter.